Book U1-SnRNP (68 KDa) - IgG antibody Test Online

How can we help?

Home

U1-SnRNP (68 KDa) - IgG antibody

Also referred as

U1-SnRNP (68 KDa) Test

For men & women

Earliest reports in

120 hours

Contains

1 test

Know more about this test

The U1-SnRNP (68 KDa) - IgG antibody test is a blood test that detects antibodies against the U1 small nuclear ribonucleoprotein (snRNP) 68 KDa component. This test helps support the evaluation of autoimmune disorders, particularly systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD).

Samples required

Blood

Find out

Why is this test booked?

Preparation for this test

Sample Collection

Who will collect your samples?

Understanding U1-SnRNP (68 KDa) - IgG antibody

U1 small nuclear ribonucleoprotein (snRNP) is a complex of proteins and RNA found in the nucleus of cells, playing a crucial role in RNA splicing (cutting and joining pieces of RNA) and processing. In certain autoimmune conditions, the immune system produces antibodies that mistakenly target the U1-snRNP complex, particularly the 68 KDa protein component. The presence of U1-snRNP (68 KDa) antibodies in the blood suggests abnormal immune activity and is considered a significant marker for specific connective tissue diseases.

U1-snRNP antibodies are strongly linked with mixed connective tissue disease (MCTD), and their detection can help differentiate MCTD from systemic lupus erythematosus (SLE), scleroderma, and other autoimmune disorders when interpreted with antinuclear antibody (ANA)/ Extractable Nuclear Antigens (ENA) and clinical findings. These antibodies may also appear in overlap syndromes and are not exclusive to one disease.

The U1-SnRNP (68 KDa) - IgG antibody test is usually recommended when individuals present with symptoms such as joint pain, muscle weakness, fatigue, Raynaud’s phenomenon, unexplained fever, or skin rashes. It is often done as part of an antinuclear antibody (ANA) panel or extractable nuclear antigen (ENA) profile for comprehensive autoimmune screening.

No special preparation, such as fasting, is required for this test. However, it is important to share the complete medical history, medications, and symptoms with the doctor, as these details help in correlating results with clinical findings. If ANA (antinuclear antibody) results are available, they should also be shared, as they provide additional context for interpreting U1-SnRNP (68 KDa) - IgG antibody results. Test results should not be interpreted in isolation but in combination with other clinical and laboratory findings to support diagnosis.

Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate and always consult a doctor to understand the test results correctly.

Please note: This is an outsourced test. The sample for this test is collected by TATA 1MG and processed at a NABL accredited partnered lab.

What does U1-SnRNP (68 KDa) - IgG antibody measure?

The U1-SnRNP (68 KDa) - IgG antibody test measures the presence of autoantibodies against the 68 KDa protein of the U1 small nuclear ribonucleoprotein (snRNP) complex in the blood. These antibodies indicate an abnormal immune response, where the body’s immune system mistakenly targets its own cells.

High levels of U1-SnRNP (68 KDa) antibodies are often seen in patients with mixed connective tissue disease (MCTD) and may also be present in systemic lupus erythematosus (SLE). Detecting these antibodies supports diagnosis and differentiation between different autoimmune disorders and guiding appropriate treatment. Low or absent levels are generally considered normal but must be interpreted in conjunction with other clinical findings and laboratory tests.

Frequently booked together

FAQs related to U1-SnRNP (68 KDa) - IgG antibody

What is the U1-SnRNP (68 KDa) - IgG antibody test?

It is a blood test that detects antibodies against the U1 small nuclear ribonucleoprotein (68 KDa). These antibodies are linked to autoimmune diseases like mixed connective tissue disease (MCTD) and systemic lupus erythematosus (SLE).

Why is this test done?

Doctors recommend this test if you have symptoms of autoimmune disease, such as fatigue, joint pain, rashes, or muscle weakness. It helps evaluate and differentiate conditions like SLE, MCTD, and other connective tissue disorders.

How is the test performed?

A phlebotomist will clean your skin using an antiseptic alcohol cotton swab or wipe and take blood samples from your vein using a needle. The blood sample will be stored safely and transported to the laboratory for analysis.

Is fasting required before the test?

No fasting or special preparation is needed.

Are there any risks with this test?

The test is safe. You may feel mild pain, swelling, or bruising at the site of blood collection, which usually goes away quickly.

What does a positive U1-SnRNP (68 KDa) - IgG antibody test result mean?

A positive result indicates the presence of antibodies against the U1 small nuclear ribonucleoprotein (68 KDa) in your blood. This suggests association with autoimmune disorders such as MCTD or SLE but is not diagnostic alone.

What does a negative result mean?

A negative result suggests that these autoantibodies are not present at detectable levels. This generally indicates a lower likelihood of MCTD or certain autoimmune conditions, but it does not completely rule out autoimmune disorders.

How is this test different from a standard ANA test?

While ANA detects general antinuclear antibodies, the U1-SnRNP (68 KDa) - IgG antibody test specifically identifies antibodies against the U1-snRNP complex, helping to distinguish MCTD from other autoimmune disorders.

How does Tata 1mg ensure accurate lab test results?

Tata 1mg ensures accurate lab test results through certified laboratories that use advanced technology and adhere to stringent quality control measures. This commitment to high standards guarantees reliable results.

Content created by